Pfenex Inc. said March 14 that Dennis Fenton will not stand for re-election to the company's board.
Fenton, who has served on the company board for three years, is stepping down of his own accord and not as a result of a disagreement, the San Diego-based clinical-stage biotechnology company said.
Further, class III director Sigurdur Olafsson was reappointed as a class I director.
With Fenton leaving, the size of the company's board will be reduced to six members, and the number of class I seats will be reduced to two.
